Mr. James Gadsby Emmett MSW

Recommended Articles

• The Battle with Insurance for Duchenne Muscular Dystrophy Coverage

  With FDA approval of Duchenne therapies, it's not far off to believe that insurance companies would change their policies and make insurance coverage for these therapies easy. However, there is still is an increasing rate of denials from insurance companies for life-saving treatments and medical...

• What are Kidney Stones: Get the Facts

  Kidney stones is a condition that's rate of infection is increasing every day especially in people aged between 20 and 40 years old. Statistics have indicated that around 20 percent of the world's population suffer from kidney stones. Among these, 20 percent are men while 10 percent are women.  ...

• Shin Splints: What Is RICE?

  he pain caused by the overuse of the shinbone, which is the large front bone in the lower leg, is known as a shin splint. Shin splints are usually characterized by pain in the inner part of the shin bone or the tibia. Shin splints are also known as medial tibial stress syndrome (MTSS). This...

• Natural Remedies for Hemorrhoids

  Hemorrhoids, also known as piles, are caused due to swollen veins around the anus or in the lower rectum. They can cause pain, severe itching and difficulty sitting. Symptoms of hemorrhoids include excessive itching, irritation and pain around the anus, painful bowel movements, incontinence, and...

• The Relationship Between Sodium and Multiple Sclerosis

  Salt is an essential element that your body requires for maintaining proper bodily functions. It helps your muscles and nerves to work to their fullest capacity and maintains the balance of fluids within your body. This, in turn, helps control your blood volume and blood pressure levels. However,...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...